CAS 209410-46-8 appears in our catalog under these names: VX 745, Neflamapimod/ 99.02% (existing batch purity), VX–745, Neflamapimod, VX-745. Offered by: TRC, TargetMol, GLPBio, Biosynth, Chemat. Available pack sizes: 10mg, 25mg, 50mg, 5mg, 100mg, 200mg, 10mM (in 1ml dmso), 1mg.
VX-745 is a member of the class of pyrimidopyridazines that is 6H-pyrimido[1,6-b]pyridazin-6-one substituted at positions 2 and 5 by (2,4-difluorophenyl)sulfanyl and 2,6-dichlorophenyl groups respectively. It has a role as an anti-inflammatory drug, an apoptosis inducer and an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a dichlorobenzene, an aryl sulfide, a difluorobenzene and a pyrimidopyridazine.
Source: ChEBI
| Molecular formula | C19H9Cl2F2N3OS |
|---|---|
| Molecular weight | 436.3 g/mol |
| IUPAC name | 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyrimido[1,6-b]pyridazin-6-one |
| InChIKey | VEPKQEUBKLEPRA-UHFFFAOYSA-N |
| SMILES | C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl |
Computed by PubChem (NCBI)